These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 5926871)

  • 1. The dose-response relation of the antidiuretic and vasopressor activities of 4-asparagine-8-lysine-vasopressin.
    Pliska V; Krejcí I
    Arch Int Pharmacodyn Ther; 1966 Jun; 161(2):289-97. PubMed ID: 5926871
    [No Abstract]   [Full Text] [Related]  

  • 2. Antidiuretic action of 1-deamino-(8-D-arginine)-vasopressin in unanesthetized rats.
    Vávra I; Machová A; Krejcí I
    J Pharmacol Exp Ther; 1974 Jan; 188(1):241-7. PubMed ID: 4809272
    [No Abstract]   [Full Text] [Related]  

  • 3. Antidiuretic and urinary cyclic AMP response of vasopressin in normal rats and in rats with lithium-polyuria.
    Christensen S; Geisler A
    Acta Pharmacol Toxicol (Copenh); 1977 Mar; 40(3):447-54. PubMed ID: 190861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sensitivity of mice to (8-arginine)- and (8-lysine)-vasopressins as antidiuretic hormones.
    Stewart AD
    J Endocrinol; 1973 Oct; 59(1):195-6. PubMed ID: 4748523
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of F-180, a new selective vasoconstrictor peptide, compared with terlipressin and vasopressin on systemic and splanchnic hemodynamics in a rat model of portal hypertension.
    Bernadich C; Bandi JC; Melin P; Bosch J
    Hepatology; 1998 Feb; 27(2):351-6. PubMed ID: 9462630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical tests with ornithine 8-vasopressin as vasoconstrictor addition to the local anesthetic solutions].
    Herfert O
    Anaesthesist; 1971 Jan; 20(1):40-1. PubMed ID: 4926016
    [No Abstract]   [Full Text] [Related]  

  • 7. Antidiuretic agonism and antagonism of some O-alkylated analogues of vasopressin containing 2-O-alkylated tyrosine.
    Melin P; Lundin S; Vilhardt H; Lindeberg G; Larsson LE; Pliska V
    Eur J Pharmacol; 1980 Oct; 67(2-3):173-7. PubMed ID: 7461030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 'Hormonogen' analogues of lysine vasopressin: rat pressor and antidiuretic activities.
    Kyncl J; Rezábek K; Kasafírek E; Pliska V; Rudinger J
    Eur J Pharmacol; 1974 Oct; 28(2):294-301. PubMed ID: 4422166
    [No Abstract]   [Full Text] [Related]  

  • 9. The mechanism of action of antidiuretic hormone.
    Corbascio AN; Dong L
    Invest Urol; 1966 Nov; 4(3):267-72. PubMed ID: 5928183
    [No Abstract]   [Full Text] [Related]  

  • 10. The bioassay of vasopressin through its antidiuretic effect.
    Guzek JW; Leśnik H
    Endokrinologie; 1968; 53(3):201-16. PubMed ID: 5713381
    [No Abstract]   [Full Text] [Related]  

  • 11. [On the inhibition of the antidiuretic effect of vasopressin and nicotine by means of acetazolamide in hydrated rats].
    Taborsky J
    Med Pharmacol Exp Int J Exp Med; 1966; 15(4):427-31. PubMed ID: 6012774
    [No Abstract]   [Full Text] [Related]  

  • 12. The antidiuretic action of vasopressin in newborn and infant rats.
    HELLER H
    J Physiol; 1951 Sep; 115(1):43 P. PubMed ID: 14898498
    [No Abstract]   [Full Text] [Related]  

  • 13. A comparison between the influence of arginine-vasopressin and lysine-vasopressin on water and electrolyte excretion in ewes.
    Kühn E
    Arch Int Pharmacodyn Ther; 1967 Aug; 168(2):417-25. PubMed ID: 6049335
    [No Abstract]   [Full Text] [Related]  

  • 14. Observations on the diuretic activity of antidiuretic hormone.
    Kramár J; Duff WM; Grinnell EH
    Am J Med Sci; 1966 Jul; 252(1):53-61. PubMed ID: 5941706
    [No Abstract]   [Full Text] [Related]  

  • 15. Biological activities of some new arginine vasopressin analogues containing unusual amino acids.
    Varga C; Somlai C; Baláspiri L; László FA
    Acta Physiol Hung; 1993; 81(2):183-92. PubMed ID: 8197874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Secondary diuresis following intravenous administration of phenylalanine-2-lysine-8-vasopressin in patients with liver cirrhosis].
    Gómez Mont F; Ramírez C; Perches A; Gómez Peralta L; Nava Lara L
    Gac Med Mex; 1967 Feb; 97(2):244-58. PubMed ID: 5612503
    [No Abstract]   [Full Text] [Related]  

  • 17. [Antidiuretic and pressor effects of arginine-8-vasopressin, lysine-8-vasopressin, phenylalanine-2-lysine-8-vasopressin in man].
    GUHL U
    Schweiz Med Wochenschr; 1961 Jul; 91():798-804. PubMed ID: 13709554
    [No Abstract]   [Full Text] [Related]  

  • 18. Relative potency of arginine-8-vasopressin and lysine-8-vasopressin in humans.
    Miller L; Fisch L; Kleeman CR
    J Lab Clin Med; 1967 Feb; 69(2):270-91. PubMed ID: 6016625
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmacological characterization of FE 202158, a novel, potent, selective, and short-acting peptidic vasopressin V1a receptor full agonist for the treatment of vasodilatory hypotension.
    Laporte R; Kohan A; Heitzmann J; Wisniewska H; Toy J; La E; Tariga H; Alagarsamy S; Ly B; Dykert J; Qi S; Wisniewski K; Galyean R; Croston G; Schteingart CD; Rivière PJ
    J Pharmacol Exp Ther; 2011 Jun; 337(3):786-96. PubMed ID: 21411496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural changes in the arginine vasopressin molecule that enhance antidiuretic activity and specificity.
    Sawyer WH; Acosta M; Balaspiri L; Judd J; Manning M
    Endocrinology; 1974 Apr; 94(4):1106-15. PubMed ID: 4818770
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.